Acutus Medical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Takeo Mukai
Chief executive officer
US$496.8k
Total compensation
| CEO salary percentage | 65.1% |
| CEO tenure | 2.3yrs |
| CEO ownership | 0.2% |
| Management average tenure | no data |
| Board average tenure | 4.2yrs |
Recent management updates
Recent updates
Investors Give Acutus Medical, Inc. (NASDAQ:AFIB) Shares A 29% Hiding
Feb 24
Market Cool On Acutus Medical, Inc.'s (NASDAQ:AFIB) Revenues Pushing Shares 43% Lower
Dec 20Take Care Before Diving Into The Deep End On Acutus Medical, Inc. (NASDAQ:AFIB)
Jul 18Acutus files for FDA approval of catheter ablation system AcQBlate
Oct 18Acutus Medical Non-GAAP EPS of -$0.93 misses by $0.17, revenue of $4.1M beats by $0.13M
Aug 11Acutus Medical sees Q2 revenue above consensus estimate
Jul 21Acutus Medical, Inc. (NASDAQ:AFIB) Analysts Just Trimmed Their Revenue Forecasts By 25%
Apr 06Acutus Medical: A Name To Slowly Accumulate
Sep 04Acutus Medical, Inc.: Paradigm-Shifting Technology At A Shocking Price
Jul 21Acutus Medical cleared to start atrial fibrillation IDE trial
May 27Analysts Have Been Trimming Their Acutus Medical, Inc. (NASDAQ:AFIB) Price Target After Its Latest Report
May 15CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$5m |
| Jun 30 2024 | n/a | n/a | -US$6m |
| Mar 31 2024 | n/a | n/a | -US$10m |
| Dec 31 2023 | US$497k | US$323k | -US$12m |
Compensation vs Market: Takeo's total compensation ($USD496.85K) is about average for companies of similar size in the US market ($USD653.16K).
Compensation vs Earnings: Insufficient data to compare Takeo's compensation with company performance.
CEO
Takeo Mukai (43 yo)
2.3yrs
Tenure
US$496,847
Compensation
Mr. Takeo Mukai serves as Chief Financial Officer (CFO) at Acutus Medical, Inc. since January 9, 2023 and serves as its Chief Executive Officer since January 2024 and served as its Senior Vice President si...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 3.8yrs | US$82.70k | 0.035% $ 546.0 | |
| Independent Director | 8.8yrs | US$68.70k | 0.042% $ 646.0 | |
| Independent Director | 3.3yrs | US$75.70k | 0.037% $ 581.4 | |
| Independent Director | 7.4yrs | US$70.70k | 0.042% $ 646.0 | |
| Independent Chairperson of the Board | 4.6yrs | US$73.70k | 0.042% $ 646.0 | |
| Independent Director | 2.3yrs | US$78.70k | 0.016% $ 242.6 |
4.2yrs
Average Tenure
51yo
Average Age
Experienced Board: AFIB's board of directors are considered experienced (4.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 08:44 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Acutus Medical, Inc. is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Hopkins | BofA Global Research |
| Michael Gorman | BTIG |
| William Plovanic | Canaccord Genuity |